Cellular FLIP (Flice-like inhibitory protein) negatively modulates the caspase 8-dependent apoptotic cascade triggered by the activation of death receptors, such as the tumor necrosis factor (TNF) 2 receptor-1 and Fas (1-3). Although the flip gene is expressed as multiple splice variants in many tissues (1, 4), it produces two major isoforms at the protein level, FLIP long (FLIP L ) and FLIP short (FLIP S ). Both isoforms contain two death effector domains in the N terminus that allow for interaction with the adapter molecule Fas-associated death domain. FLIP L , the more abundantly expressed isoform in most cell types, additionally contains an nonfunctional caspase activation-like domain in its C terminus (1). The increased expression of FLIP renders tumor cells and macrophages from the joints of patients with rheumatoid arthritis resistant to death receptor and chemotherapeutic drug-mediated apoptosis (5-8), whereas the level of FLIP correlates with tumor progression and patient outcomes (9).To date, the transcriptional and post-transcription regulation of FLIP has not been fully elucidated. NF-B strongly upregulates the expression of FLIP L and FLIP S (10), and TNF␣ and LPS, which activate NF-B, are known to induce FLIP (11,12). Additionally, Akt has been implicated in the induction of FLIP (13-16). Post-transcriptionally, FLIP L and FLIP S are regulated by ubiquitin-proteasome pathway (17-20). As reported recently (21), the TNF␣-accelerated FLIP L turnover in mouse hepatocytes and mouse embryonic fibroblasts was mediated through JNK activation that occurs when NF-B activation is suppressed. The JNK-mediated phosphorylation of E3 ubiquitin ligase Itch results in the ubiquitination and degradation of FLIP L . However, the role of TNF␣ in the post-transcriptional regulation of FLIP in the absence of NF-B inhibition or the prolonged activation of JNK is not known.The dysregulation of macrophage function contributes to the pathogenesis of rheumatoid arthritis, inflammatory bowel disease, atherosclerosis, and chronic obstructive pulmonary disease (22)(23)(24)(25)(26). Our prior observations demonstrate that FLIP is critical for the protection of macrophages against death receptor-mediated apoptosis in rheumatoid arthritis (8, 27); however, knowledge of the mechanisms that regulate FLIP in macrophages is incomplete. While characterizing the expression of FLIP in macrophages, in contrast to expectations, we noticed that activation with TNF␣ or LPS actually reduced the protein levels of FLIP L , but not FLIP S , at 1 and 2 h, even though the mRNA of both isoforms was increased. The activation-induced reduction of FLIP L resulted in the increased activation of caspase 8, which promoted the activation of NF-B and the expression of FLIP mRNA. Our observations also demonstrate that the PI3K/Akt-1 (Akt) pathway mediates the activationinduced reduction of FLIP L by the phosphorylation of FLIP L at serine 273. These observations identify a novel pathway regulating the decision for life and death of the macrophage following ...